Changes in the properties of allosteric and orthosteric GABAB receptor ligands after a continuous, desensitizing agonist pretreatment

被引:9
|
作者
Gjoni, Tina [1 ]
Urwyler, Stephan [1 ]
机构
[1] Novartis Inst Biomed Res, Basel, Switzerland
关键词
GABA(B) receptor; Constitutive activity; Inverse agonism; Allosteric modulator; Desensitization; Ligand property; Efficacy; PROTEIN-COUPLED RECEPTORS; MU-OPIOID-RECEPTOR; INVERSE AGONISTS; CONSTITUTIVE ACTIVITY; N,N'-DICYCLOPENTYL-2-METHYLSULFANYL-5-NITRO-PYRIMIDINE-4,6-DIAMINE GS39783; NEUTRAL ANTAGONISTS; HEPTAHELICAL DOMAIN; SIGNALING PROTEINS; POINT MUTATIONS; 2-STATE MODEL;
D O I
10.1016/j.ejphar.2008.12.014
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
It has been estimated that only 15% of the compounds classified as silent G protein-coupled receptor antagonists are indeed devoid of either positive or negative intrinsic efficacy. Considering that 40% of all drugs on the market target G protein-coupled receptors mainly as orthosteric ligands, elucidating their intrinsic properties is becoming increasingly important. While agonism can be demonstrated using appropriately sensitive experimental setups, the detection of inverse agonism can be limited by a low degree of constitutive activity in many assay systems. In this study, changes in ligand behavior upon a lasting pretreatment with gamma-aminobutyric acid (GAB(B)), that induced receptor desensitization, were observed, measuring the second messenger cyclic AMP (cAMP) in a GABA(B) receptor-expressing recombinant cell line. The GABA(B) receptor partial agonist 2-OH-saclofen lost its ability to inhibit 7 beta-forskolin-induced cAMP production upon GAB(A)-pretreatment. The "silent" receptor antagonists CGP62349, CGP52432, CGP56999 and SCH50911, on the other hand, stimulated 7 beta-forskolin-induced cAMP production under these conditions. The inverse agonism of CGP56999 was inhibited by the efficacy-deficient 2-OH-saclofen, proving it was truly mediated through the orthosteric site of the GABA(B) receptor. Finally, the positive allosteric modulator GS39783, which previously only marginally inhibited cAMP production, suppressed it by 60% both alone and in the presence of the competitive receptor antagonist 2-OH-saclofen, thus GS39783 became an allosteric receptor agonist at desensitized GABA(B) receptors. These changes likely reflect adaptations in the mechanisms of GABA(B) receptor function following desensitization and may be important in the elucidation of intrinsic ligand efficacies as well as for the consequences of continuous drug treatment. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:37 / 41
页数:5
相关论文
共 50 条
  • [31] Effects of co-administration of the GABAB receptor agonist baclofen and a positive allosteric modulator of the GABAB receptor, CGP7930, on the development and expression of amphetamine-induced locomotor sensitization in rats
    Laura N. Cedillo
    Florencio Miranda
    Pharmacological Reports, 2013, 65 : 1132 - 1143
  • [32] Design, synthesis and biological evaluation of novel orthosteric-allosteric ligands of the cannabinoid receptor type 2 (CB2R)
    Ferrisi, Rebecca
    Gado, Francesca
    Polini, Beatrice
    Ricardi, Caterina
    Mohamed, Kawthar A. A.
    Stevenson, Lesley A. A.
    Ortore, Gabriella
    Rapposelli, Simona
    Saccomanni, Giuseppe
    Pertwee, Roger G. G.
    Laprairie, Robert B. B.
    Manera, Clementina
    Chiellini, Grazia
    FRONTIERS IN CHEMISTRY, 2022, 10
  • [33] Effects of co-administration of the GABAB receptor agonist baclofen and a positive allosteric modulator of the GABAB receptor, CGP7930, on the development and expression of amphetamine-induced locomotor sensitization in rats
    Cedillo, Laura N.
    Miranda, Florencio
    PHARMACOLOGICAL REPORTS, 2013, 65 (05) : 1132 - 1143
  • [34] Comparison of the Effect of the GABAB Receptor Agonist, Baclofen, and the Positive Allosteric Modulator of the GABAB Receptor, GS39783, on Alcohol Self-Administration in 3 Different Lines of Alcohol-Preferring Rats
    Maccioni, Paola
    Zaru, Alessandro
    Loi, Barbara
    Lobina, Carla
    Carai, Mauro A. M.
    Gessa, Gian Luigi
    Capra, Alessandro
    Mugnaini, Claudia
    Pasquini, Serena
    Corelli, Federico
    Hyytia, Petri
    Lumeng, Lawrence
    Colombo, Giancarlo
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2012, 36 (10) : 1748 - 1766
  • [35] GABAB receptor activation changes membrane and filter properties of auditory thalamic neurons
    Tennigkeit, F
    Schwarz, DWF
    Puil, E
    HEARING RESEARCH, 1998, 122 (1-2) : 18 - 24
  • [36] Effect of the tyramine fragment of opioid receptor ligands on their agonist and antagonist properties
    Kuz'mina N.E.
    Osipova E.S.
    Kuz'min V.S.
    Sitnikov V.B.
    Pharmaceutical Chemistry Journal, 2006, 40 (5) : 254 - 260
  • [37] A Novel Mechanism of G Protein-coupled Receptor Functional Selectivity MUSCARINIC PARTIAL AGONIST McN-A-343 AS A BITOPIC ORTHOSTERIC/ALLOSTERIC LIGAND
    Valant, Celine
    Gregory, Karen J.
    Hall, Nathan E.
    Scammells, Peter J.
    Lew, Michael J.
    Sexton, Patrick M.
    Christopoulos, Arthur
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (43) : 29312 - 29321
  • [38] Effects of GABAB receptor antagonist, agonist and allosteric positive modulator on the cocaine-priming, discrete contextual cues and food induced relapses
    Frankowska, M.
    Filip, M.
    Przegalinski, E.
    BEHAVIOURAL PHARMACOLOGY, 2007, 18 : S25 - S25
  • [39] M2 Subtype preferring dibenzodiazepinone-type muscarinic receptor ligands: Effect of chemical homo-dimerization on orthosteric (and allosteric?) binding
    Keller, Max
    Traenkle, Christian
    She, Xueke
    Pegoli, Andrea
    Bernhardt, Guenther
    Buschauer, Armin
    Read, Roger W.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (14) : 3970 - 3990
  • [40] Pretreatment of Rats with an Allosteric Luteinizing Hormone Receptor Agonist Enhances Chorionic Gonadotropin-Induced Stimulation of Testosterone Production
    A. O. Shpakov
    A. A. Bakhtyukov
    D. V. Dar’in
    K. V. Derkach
    Journal of Evolutionary Biochemistry and Physiology, 2019, 55 : 510 - 514